GAS5 and colorectal carcinoma: Plasma EV-derived Growth Arrest Specific 5 (GAS5) was analyzed between control (178) and CRC (153) patients, could distinguish between the two groups with an AUC of 0.964 and was observed to be associated with the TNM stage, LNM, local recurrence rate and distant metastasis rate.